We evaluated the elimination of COZ in three Japanese adults with carbonic anhydrase II (CA II) deficiency, as compared with that in 10 healthy volunteers. The patients had no signs of respiratory distress. Heart rate, body temperature, ventilation volume, respiratory rate and (a -ET) PC02 were found to be higher and PaCOZ tended to be higher in the patients than those in the volunteers, while forced vital capacity (FVC), forced expiratory volume in 1s (FEV,), tidal volume, end-tidal PC02 (PETCO~), pH and HC03-in arterial blood were lower in the patients. All three patients had non-anion-gap metabolic acidosis, due to renal losses of bicarbonate, but with virtually no compensatory reduction in PaC02. However, the high QE and Pa02 suggested that respiratory compensation for this metabolic acidosis was occuring, the elimination of COZ was possibly facilitated by the presence of other carbonic anhydrase isoenzymes in the pulmonary capillaries. Thus, CA II deficiency causes mild to moderate impairments in CO2 elimination.
Introduction
Three Japanese patients with a carbonic anhydrase II (CAII) deficiency were previously reported to have renal tubular acidosis, a disturbance in calcium metabolism with cerebral calcifications, osteopetrosis and mental problems (l-3). Ohlsson et al. have previously reported a restrictive defect in pulmonary function, but no evidence of respiratory distress or of parenchymal lung disease in such patients (4) . We hypothesized that CO* elimination is reduced when the velocity of chemical reaction between COZ and HCO; is decreased by inhibiting carbonic anhydrase (5, 6) . In this study, we compared the respiratory function of three patients, in whom carbonic anhydrase activity had been reported previously (l-3), with that of healthy volunteers.
Case Histories
Three patients were studied: patient A, a 27-year-old woman; patient B, a 30-year-old woman; and patient C, a 36-year-old man (1, 7) . Only one (patient C) had consanguinous parents (first cousins). Osteopetrosis, attacks of muscle weakness associated with hypokalaemia, and metabolic acidosis (non-anion gap) occurred in all three. All
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Results
The clinical characteristics of the patients and the volunteers are summarized in Table 1 and Fig. 1 . The patients were older and lighter than the volunteers.
FVC in the patients was lower than in the healthy adults although the FEVJFVC ratio was normal. All three patients had non-anion gap metabolic acidosis. Their VE and RR exceeded those of the volunteers and their TV was low. The patients exhibited lover PETCO~, pH, and HCOsthan the volunteers. The PaC02, values are normal. The PaCO, values in the patients, although they did not differ significantly from those in the volunteers, were near the upper limit of normal and were higher than expected for the pH level ( Table 1 ). The patients exhibited higher (a -ET)PCOa values than the volunteers. Physiological VD/ VT in patient C was high. $'COz and PO, in patients C were lower than in the volunteers, and EE in patient C and in the volunteers was lower than the predicted basal metabolic energy.
Discussion
Osteopetrosis with renal tubular acidosis and cerebral calcification was described in CA II deficiency by three independent groups in 1972 (&lo), and a number of subsequent cases have been reported (4, (11) (12) (13) (14) (15) . Similar calcifications have been seen after the administration of massive doses of acetazolamide (100 mg kg-'), an inhibitor of carbonic anhydrase (16) . None of the reports have discussed any disturbances in CO2 elimination by the lungs, as might be expected, considering that CA inhibition can impair CO2 elimination in normal mammals (5, 6, 17) . All three of our patients had mild restrictive lung disease and abnormally dense ribcages, which may suggest a type of chest-wall restriction. All three also had alveolar hyperventilation, as indicated by their low PETCO~ values. However, none of them had low PaC02 values and their acid-based status would classically be defined as mixed metabolic and respiratory acidosis.
The elimination of COZ is controlled by ventilation, circulation and the conversion velocity of HCO, to CO*. Na (mEq 1 -') Cl (mEq 1-i) Anion (mEq l-') gap liCOz (ml min-') vO2 (ml min-') EE (cal day-') Basal metabolic energy (cal day-') Haris-Benedict Fleisch All three of our patients had high levels of minute ventilation and appropriately low PETCO~. The absence of carbonic anhydrase and the consequent impaired conversion of HCO; to COZ led to elevated PaC02 -&rC02, gradients, (a-ET) PCO2, ranging from 4.6 to 10.3 mmHg (5, 6, 17, 18) . These increased (a-ET)PCOz values, while above normal, are less than the gradients that have previously been observed after carbonic anhydrase inhibition (6). Our patients possibly had relatively high cardiac outputs, which helped to maintain low (a-ET) PC02 values, as has previously been observed in patients with hyperthyroidism and reduced carbonic anhydrase activity (19, 20) . The excretion of CO2 can also be influenced by CA I in red cells and by pulmonary CA IV. The total CA activity in our patients may have been sufficient to deliver the CO2 produced to the circulating erythrocytes and to eliminate CO2 from the lungs. The exercise intolerance seen in our patients may have been due to a failure of this system when CO2 production increased.
